What Bicara Therapeutics Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 1 |
| Sells | 5 | 57 |
| Total trades | 9 | 105 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 58,750 | 796,312 |
| Disposed | 58,750 | 456,263 |
| Net activity | +0 | +340,049 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Cohlhepp Ryan | President, COO & Interim CEO | Sep 08 | Open-market sale · S | −3,442 | $23.43 | −$80.7K | 181,641 |
| Cohlhepp Ryan | President, COO & Interim CEO | Sep 08 | Open-market sale · S | −14,058 | $22.77 | −$320K | 185,083 |
| Cohlhepp Ryan | President, COO & Interim CEO | Sep 08 | Exercise / conversion · M | +17,500 | $3.79 | +$66.3K | 199,141 |
| Mazumdar Claire | Chief Executive Officer | Aug 10 | Open-market sale · S | −10,000 | $27.98 | −$280K | 362,152 |
| Mazumdar Claire | Chief Executive Officer | Aug 10 | Exercise / conversion · M | +10,000 | $3.79 | +$37.9K | 372,152 |
| Hyep Ivan | Chief Financial Officer | Aug 10 | Open-market sale · S | −12,500 | $27.97 | −$350K | 129,855 |
| Hyep Ivan | Chief Financial Officer | Aug 10 | Exercise / conversion · M | +12,500 | $3.79 | +$47.4K | 142,355 |
| Cohlhepp Ryan | President and COO | Aug 10 | Open-market sale · S | −18,750 | $27.98 | −$525K | 181,641 |
| Cohlhepp Ryan | President and COO | Aug 10 | Exercise / conversion · M | +18,750 | $3.79 | +$71.1K | 200,391 |
| Mazumdar Claire | Chief Executive Officer | Jul 10 | Open-market sale · S | −28 | $29.68 | −$831 | 362,152 |
| Mazumdar Claire | Chief Executive Officer | Jul 10 | Open-market sale · S | −9,972 | $28.42 | −$283K | 362,180 |
| Mazumdar Claire | Chief Executive Officer | Jul 10 | Exercise / conversion · M | +10,000 | $3.79 | +$37.9K | 372,152 |
| Cohlhepp Ryan | President and COO | Jul 09 | Open-market sale · S | −536 | $29.00 | −$15.5K | 181,641 |
| Cohlhepp Ryan | President and COO | Jul 08 | Open-market sale · S | −1,075 | $30.35 | −$32.6K | 182,177 |
| Cohlhepp Ryan | President and COO | Jul 08 | Open-market sale · S | −4,306 | $29.80 | −$128K | 183,252 |
| Cohlhepp Ryan | President and COO | Jul 08 | Open-market sale · S | −22,833 | $28.76 | −$657K | 187,558 |
| Cohlhepp Ryan | President and COO | Jul 08 | Exercise / conversion · M | +18,750 | $3.79 | +$71.1K | 210,391 |
| Hyep Ivan | Chief Financial Officer | Jul 08 | Open-market sale · S | −830 | $30.31 | −$25.2K | 129,855 |
| Hyep Ivan | Chief Financial Officer | Jul 08 | Open-market sale · S | −4,413 | $29.82 | −$132K | 130,685 |
| Hyep Ivan | Chief Financial Officer | Jul 08 | Open-market sale · S | −22,757 | $28.60 | −$651K | 135,098 |
Loading...
